Astrana Health, Inc.: share-based compensation expense
Share-based compensation expense for Astrana Health, Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Astrana Health, Inc. financial histories
What this measure means
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
Exact concept: us-gaap:ShareBasedCompensation. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-02-01 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2025-01-01 | 2025-12-31 | 38,601,000 | USD | 2026-03-12 | 10-K · 0001193125-26-103128 |
| 2024-01-01 | 2024-12-31 | 34,536,000 | USD | 2026-03-12 | 10-K · 0001193125-26-103128 |
| 2023-01-01 | 2023-12-31 | 22,040,000 | USD | 2026-03-12 | 10-K · 0001193125-26-103128 |
| 2022-01-01 | 2022-12-31 | 16,101,000 | USD | 2025-03-14 | 10-K · 0000950170-25-039122 |
| 2021-01-01 | 2021-12-31 | 6,745,000 | USD | 2024-02-29 | 10-K · 0001628280-24-008024 |
| 2020-01-01 | 2020-12-31 | 3,383,000 | USD | 2023-08-09 | 10-K/A · 0001628280-23-028675 |
| 2019-01-01 | 2019-12-31 | 1,547,000 | USD | 2022-02-28 | 10-K · 0001628280-22-004291 |
| 2018-01-01 | 2018-12-31 | 1,441,000 | USD | 2021-03-15 | 10-K · 0001628280-21-004679 |
| 2017-01-01 | 2017-12-31 | 2,743,116 | USD | 2020-03-16 | 10-K · 0001628280-20-003626 |
| 2013-02-01 | 2014-01-31 | 12,602 | USD | 2014-05-08 | 10-K · 0001144204-14-028378 |
Related financial histories
- Astrana Health, Inc.: total assets
- Astrana Health, Inc.: total liabilities
- Astrana Health, Inc.: stockholders equity
- Astrana Health, Inc.: cash and cash equivalents
- Astrana Health, Inc.: net income or loss
- Astrana Health, Inc.: operating cash flow
- Astrana Health, Inc.: capital expenditure payments
- Astrana Health, Inc.: revenue
- Astrana Health, Inc.: contract revenue excluding tax
- Astrana Health, Inc.: financing cash flow
- Astrana Health, Inc.: investing cash flow
- Astrana Health, Inc.: retained earnings or deficit
- Astrana Health, Inc.: basic weighted-average shares
- Astrana Health, Inc.: diluted weighted-average shares
- Astrana Health, Inc.: basic earnings per share
- Astrana Health, Inc.: diluted earnings per share
- Astrana Health, Inc.: income tax expense or benefit
- Astrana Health, Inc.: net property, plant and equipment
- Astrana Health, Inc.: operating income or loss
- Astrana Health, Inc.: current assets
- Astrana Health, Inc.: interest expense
- Astrana Health, Inc.: current liabilities
- Astrana Health, Inc.: current accounts payable
- Astrana Health, Inc.: goodwill carrying amount
- Astrana Health, Inc.: net finite-lived intangible assets
- Astrana Health, Inc.: net current accounts receivable
- Astrana Health, Inc.: common-stock repurchase payments
- Astrana Health, Inc.: operating expenses
- Astrana Health, Inc.: gross profit
Inspect the source
- Entity
- Astrana Health, Inc. / CIK 0001083446
- Captured
- 2026-09-20T05:20:50.832Z
- SEC response SHA-256
24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))